bims-maitce Biomed News
on MAIT cells
Issue of 2023–12–31
one paper selected by
Andy E. Hogan, Maynooth University



  1. Inflamm Res. 2023 Dec 26.
       OBJECTIVE: Here, we explored the phenotype and function of MAIT cells in the peripheral blood of patients with HSP.
    METHODS: Blood samples from HSP patients and HDs were assessed by flow cytometry and single-cell RNA sequencing to analyze the proportion, phenotype, and function of MAIT cells. Th-cytokines in the serum of HSP patients were analyzed by CBA. IgA in cocultured supernatant was detected by CBA to analyze antibody production by B cells.
    RESULTS: The percentage of MAIT cells in HSP patients was significantly reduced compared with that in HDs. Genes related to T cell activation and effector were up-regulated in HSP MAIT cells, indicating a more activated phenotype. In addition, HSP MAIT cells displayed a Th2-like profile with the capacity to produce more IL-4 and IL-5, and IL-4 was correlated with IgA levels in the serum of HSP patients. Furthermore, CD40L was up-regulated in HSP MAIT cells, and CD40L+ MAIT cells showed an increased ability to produce IL-4 and to enhance IgA production by B cells.
    CONCLUSION: Our data demonstrate that MAIT cells in HSP patients exhibit an activated phenotype. The enhanced IL-4 production and CD40L expression of MAIT cells in HSP patients could take part in the pathogenesis of HSP.
    Keywords:  CD40L; Heonch–Schönlein purpura; IL-4; IgA; MAIT
    DOI:  https://doi.org/10.1007/s00011-023-01816-x